Abstract
The ongoing coronavirus disease 2019 (COVID-19), one of the deadliest pandemics in history, is associated with significant considerations for people living with multiple sclerosis (plwMS). The interest is motivated by knowing that viral infections are triggers for disease exacerbation [1]. In this chronic inflammatory demyelinating disorder of the central nervous system (CNS), relapses associated with infectious stimuli lead to more prolonged and severe clinical worsening than spontaneous relapses [2].
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
